How to make an antibody - Works in Progress Magazine
Antibody therapies make up four of the world’s ten best selling drugs. If they were cheaper, they could prevent millions of deaths from rabies, malaria, and dengue.
Diphtheria , the strangling angel, was one of the great killers of children in the 19th century. The infection owes its lethality to a potent toxin released by the bacteria Corynebacterium diphtheriae . Diphtheria toxin destroys the heart, lungs, and liver. In the late stages of disease, the infected are suffocated by a buildup of dead, grey, tissue in their throats. Most victims were children under five; before modern treatments, as many as half of infected babies and toddlers died. There was little parents and doctors could do against the scourge, until biotechnology provided the first answe
related reading
- A primer on machine learning in antibody engineeringabhishaike.com
- Phage Display Derived Monoclonal Antibodies: From Bench to Bedsidencbi.nlm.nih.gov
- Medicine's Endgamenotboring.co
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- The golden age of vaccine development - Works in Progress Magazineworksinprogress.co
- Why we didn't get a malaria vaccine sooner - Works in Progress Magazineworksinprogress.co
- In vitro-engineered non-antibody protein therapeuticsncbi.nlm.nih.gov
- Neion Bioneionbio.com
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Frontiers | Therapeutic Antibodies against Intracellular Tumor Antigensfrontiersin.org
- Boosting therapeutic potency of antibodies by taming Fc domain functions | Experimental & Molecular Medicinenature.com
- Mesa — JURA Bio, Inc.jura.bio